JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Italy Fines Apple €98.6 Million Over App Store Dominance 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
FDA Approves Mitapivat for Anemia in Thalassemia Patients 
WOBURN, Mass., July 27, 2017 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that the Company plans to release its second quarter 2017 financial results and host a conference call with management after market close on Thursday, August 10, 2017.
Shareholders will participate in the call in listen-only mode. The Company invites shareholders to submit questions for consideration by August 7, 2017 to [email protected] with the subject line: “Questions for Second Quarter 2017 Conference Call.” Questions submitted in advance of the call will be reviewed and some will be addressed in management's prepared remarks or in the Q&A portion of the call.
Interested participants can join the conference call using the following numbers:
U.S. Toll-free dial-in: 1-877-709-8150
International dial-in: 201-689-8354
Event Date/Time: Thursday, August 10 at 4:30 p.m. ET
A live webcast of the call including the slide deck can be accessed through the investor relations section of the Company’s website at www.yield10bio.com. The webcast will be archived on the Company’s website in the investor relations section.
To listen to a telephonic replay of the conference call, dial 877-660-6853 (toll-free) or 201-612-7415 (international) and enter passcode 13665015. The replay will be available for 14 days.
About Yield10
Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security. Yield10 has an extensive track record of innovation based around optimizing the flow of carbon in living systems. Yield10 is leveraging its technology platforms and unique knowledge base to design precise alterations to gene activity and the flow of carbon in plants to produce higher yields with lower inputs of land, water or fertilizer. Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and corn. Yield10 is headquartered in Woburn, MA and has an Oilseeds center of excellence in Saskatoon, Canada.
For more information about the Company, please visit www.yield10bio.com. (YTEN-E)
Yield10 Inquiries: Lynne H. Brum, (617) 682-4693, [email protected] Investor Relations Contact: Amato and Partners, LLC 90 Park Avenue, 17th Floor New York, NY 10016 [email protected]
